Rinne M Peters1, Femke M A P Claessen2, Job N Doornberg3, Gregory P Kolovich2, Ron L Diercks4, Michel P J van den Bekerom5. 1. University of Groningen, Department of Orthopaedic Surgery, University Medical Center Groningen Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: rinnepeters27@hotmail.com. 2. Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital, Boston, MA, USA. 3. University of Amsterdam, Orthopaedic Residency Program (PGY 5), Orthotrauma Research Center, Amsterdam, The Netherlands. 4. University of Groningen, Department of Orthopaedic Surgery, University Medical Center Groningen Hanzeplein 1, 9713 GZ Groningen, The Netherlands. 5. Shoulder and Elbow Unit, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Abstract
INTRODUCTION: Humeral shaft nonunions can lead to morbidity from subsequent operations, complications and impaired function. Currently there is no evidenced-based consensus for treatment of humeral shaft nonunions. AIM: We aimed to summarize and analyze union rates and complications after operative treatment for humeral shaft nonunion. METHODS: Studies investigating operative treatment strategies for humeral shaft nonunion were identified by searching: EMBASE, MEDLINE, Ovid SP, Web of Science, Cochrane Central, PubMed and Google Scolar up to October 24, 2014. Studies were eligible if: (1) outcome of operative treatment for humeral shaft nonunion was reported; (2) at least ten adult patients with humeral shaft nonunion included; (3) full text article available; (4) written in English, German or Dutch; and (5) nonunion was defined as no bone-bridging between the fracture ends after 6 months. RESULTS: Thirty-six studies were included. A union rate of 98% was found in patients (n=672) who underwent plate fixation with autologous bone grafting (ABG), 95% in plate fixation without ABG (n=19), 88% in intramedullary nailing with ABG (n=164), 66% in intramedullary nailing without ABG (n=78), 92% in bone strut fixation (n=91) and 98% in external fixation (n=152). A total complication rate of 12% was found in patients treated with plate fixation combined with ABG, 15% in intramedullary nail with ABG and 8% intramedullary nailing without ABG, 20% in bone strut fixation and 22% in external fixation. CONCLUSION: Plate fixation with ABG was recommended for humeral shaft nonunion, since the union rate is highest and the complication rate is relatively low. LEVEL OF EVIDENCE: Level IV.
INTRODUCTION: Humeral shaft nonunions can lead to morbidity from subsequent operations, complications and impaired function. Currently there is no evidenced-based consensus for treatment of humeral shaft nonunions. AIM: We aimed to summarize and analyze union rates and complications after operative treatment for humeral shaft nonunion. METHODS: Studies investigating operative treatment strategies for humeral shaft nonunion were identified by searching: EMBASE, MEDLINE, Ovid SP, Web of Science, Cochrane Central, PubMed and Google Scolar up to October 24, 2014. Studies were eligible if: (1) outcome of operative treatment for humeral shaft nonunion was reported; (2) at least ten adult patients with humeral shaft nonunion included; (3) full text article available; (4) written in English, German or Dutch; and (5) nonunion was defined as no bone-bridging between the fracture ends after 6 months. RESULTS: Thirty-six studies were included. A union rate of 98% was found in patients (n=672) who underwent plate fixation with autologous bone grafting (ABG), 95% in plate fixation without ABG (n=19), 88% in intramedullary nailing with ABG (n=164), 66% in intramedullary nailing without ABG (n=78), 92% in bone strut fixation (n=91) and 98% in external fixation (n=152). A total complication rate of 12% was found in patients treated with plate fixation combined with ABG, 15% in intramedullary nail with ABG and 8% intramedullary nailing without ABG, 20% in bone strut fixation and 22% in external fixation. CONCLUSION: Plate fixation with ABG was recommended for humeral shaft nonunion, since the union rate is highest and the complication rate is relatively low. LEVEL OF EVIDENCE: Level IV.
Authors: Markus Rupp; Christoph Biehl; Matthäus Budak; Ulrich Thormann; Christian Heiss; Volker Alt Journal: Int Orthop Date: 2017-12-22 Impact factor: 3.075
Authors: Angelos Kaspiris; Argyris C Hadjimichael; Elias S Vasiliadis; Dionysios J Papachristou; Peter V Giannoudis; Elias C Panagiotopoulos Journal: J Clin Med Date: 2022-07-04 Impact factor: 4.964
Authors: Simon Hackl; Christian Hierholzer; Jan Friederichs; Alexander Woltmann; Volker Bühren; Christian von Rüden Journal: BMC Musculoskelet Disord Date: 2017-08-07 Impact factor: 2.362